HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

Highlights Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-04-29 am EDT			5-day change	1st Jan Change
17.48 ^HKD	+1.51%		+13.65%	+10.91%

Apr. 03	Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug	MT
Apr. 03	Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug	Apr. 03	MT
Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer	Apr. 03	CI
Hansoh Pharmaceutical Group Company Limited Recommends Final Dividend, Payable on July 17, 2024	Mar. 26	CI
Hansoh Pharmaceutical Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Hansoh Pharmaceutical Gets Nod to Trial Nephropathy Treatment Capsules	Feb. 08	MT
Hansoh Pharmaceutical Buys Back 3 Million Shares	Jan. 31	MT
Hansoh Secures Chinese Nod For Clinical Trial Of Anti-Diabetes Drug	Jan. 23	MT
Hansoh Pharmaceutical Units Gets Clinical Trial Notice in China for Schizophrenia Treatment	Jan. 17	MT
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of HS-10509 Tablets	Jan. 17	CI
Hansoh Pharmaceutical’s Trustee Buys Back Shares	Jan. 02	MT
GSK plc Enters Exclusive License Agreement with Hansoh for HS-20093	Dec. 20	CI
GSK looks for deals in China as rebuilds relationship	Dec. 17	AN
Hansoh Pharma's Three Drugs Added to China’s National Reimbursement Drug List	Dec. 14	MT
China OKs Clinical Trial for Hansoh Pharmaceutical Units' Hypertrophic Cardiomyopathy Treatment	Nov. 12	MT
Shanghai Hansoh Biomedical Technology Company Limited and Jiangsu Hansoh Pharmaceutical Group Company Limited Receives Clinical Trial Notice	Nov. 10	CI
China Grants Drug Registration Approval for Hansoh Pharma Unit's Skin Infection Treatment	Nov. 02	MT
Hansoh Pharmaceutical Gets Nod to Test HS-20106 Injections	23-10-20	MT
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of Hs-20106 Injections	23-10-19	CI
Hansoh Pharmaceutical Units Obtain Clinical Trial Approval for Solid Tumor Drug	23-09-25	MT
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of "HS-20105"	23-09-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Highlights

Filters